These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38866911)

  • 1. Whole body physiology model to simulate respiratory depression of fentanyl and associated naloxone reversal.
    Baird A; White SA; Das R; Tatum N; Bisgaard EK
    Commun Med (Lond); 2024 Jun; 4(1):114. PubMed ID: 38866911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.
    Dahan A; Franko TS; Carroll JW; Craig DS; Crow C; Galinkin JL; Garrity JC; Peterson J; Rausch DB
    Front Public Health; 2024; 12():1346109. PubMed ID: 38481848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic considerations for community-based dosing of nasal naloxone in opioid overdose in adults.
    Dale O
    Expert Opin Drug Metab Toxicol; 2022 Mar; 18(3):203-217. PubMed ID: 35500297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest.
    Mann J; Samieegohar M; Chaturbedi A; Zirkle J; Han X; Ahmadi SF; Eshleman A; Janowsky A; Wolfrum K; Swanson T; Bloom S; Dahan A; Olofsen E; Florian J; Strauss DG; Li Z
    Clin Pharmacol Ther; 2022 Nov; 112(5):1020-1032. PubMed ID: 35766413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentanyl: a comparison of blood fentanyl concentrations and naloxone dosing after non-fatal overdose.
    Krotulski AJ; Chapman BP; Marks SJ; Ontiveros ST; Devin-Holcombe K; Fogarty MF; Trieu H; Logan BK; Merchant RC; Babu KM
    Clin Toxicol (Phila); 2022 Feb; 60(2):197-204. PubMed ID: 34278904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders.
    Abdelal R; Raja Banerjee A; Carlberg-Racich S; Darwaza N; Ito D; Shoaff J; Epstein J
    Harm Reduct J; 2022 May; 19(1):49. PubMed ID: 35596213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest.
    Laffont CM; Purohit P; Delcamp N; Gonzalez-Garcia I; Skolnick P
    Front Psychiatry; 2024; 15():1399803. PubMed ID: 38952632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
    Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
    J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time Course of Reversal of Fentanyl-Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone.
    Cipriano A; Apseloff G; Kapil RP; He E; Shet M; Harris SC
    J Clin Pharmacol; 2024 Sep; ():. PubMed ID: 39347921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of naloxone dosing patterns for opioid overdose by emergency medical services in Kentucky during increased fentanyl use from 2018 to 2021.
    Rock P; Slavova S; Westgate PM; Nakamura A; Walsh SL
    Drug Alcohol Depend; 2024 Feb; 255():111062. PubMed ID: 38157702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic opioids have disrupted conventional wisdom for treating opioid overdose.
    Skolnick P; Paavola J; Heidbreder C
    Drug Alcohol Depend Rep; 2024 Sep; 12():100268. PubMed ID: 39262668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients.
    Amaducci A; Aldy K; Campleman SL; Li S; Meyn A; Abston S; Culbreth RE; Krotulski A; Logan B; Wax P; Brent J; Manini AF;
    JAMA Netw Open; 2023 Aug; 6(8):e2331264. PubMed ID: 37642962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stronger, longer, better opioid antagonists? Nalmefene is NOT a naloxone replacement.
    Infante AF; Elmes AT; Gimbar RP; Messmer SE; Neeb C; Jarrett JB
    Int J Drug Policy; 2024 Feb; 124():104323. PubMed ID: 38232438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline reverses oxycodone's but not fentanyl's respiratory depression in mice while caffeine is ineffective against both opioids.
    Elder HJ; Walentiny DM; Beardsley PM
    Pharmacol Biochem Behav; 2023 Aug; 229():173601. PubMed ID: 37414364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of opioid overdose: current approaches and recent advances.
    Britch SC; Walsh SL
    Psychopharmacology (Berl); 2022 Jul; 239(7):2063-2081. PubMed ID: 35385972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
    Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
    Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overdoses due to fentanyl and its analogues (F/FAs) push naloxone to the limit.
    Pergolizzi JV; Dahan A; Ann LeQuang J; Raffa RB
    J Clin Pharm Ther; 2021 Dec; 46(6):1501-1504. PubMed ID: 34111307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic review.
    Moe J; Godwin J; Purssell R; O'Sullivan F; Hau JP; Purssell E; Curran J; Doyle-Waters MM; Brasher PMA; Buxton JA; Hohl CM
    CJEM; 2020 Mar; 22(2):178-186. PubMed ID: 31955714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prepacked naloxone administration for suspected opioid overdose in the era of illicitly manufactured fentanyl: a retrospective study of regional poison center data.
    Mahonski SG; Leonard JB; Gatz JD; Seung H; Haas EE; Kim HK
    Clin Toxicol (Phila); 2020 Feb; 58(2):117-123. PubMed ID: 31092050
    [No Abstract]   [Full Text] [Related]  

  • 20. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.